Toluene Urinary Metabolites: Sampling Timing, Saturation, and the Obese Worker
A laminating plant uses a toluene-based contact cement applied by hand (no local exhaust, cotton gloves only). Personal 8-hour air sampling gives a TWA of 95 ppm (ACGIH TLV 20 ppm; OSHA PEL 200 ppm). Six workers provide urine at the end of the shift and again before the next shift: end-of-shift o-cresol averages 1.7 g/g creatinine, pre-shift 0.35 g/g creatinine. One worker (BMI 38) has a post-shift blood toluene of 1.9 mg/L versus roughly 0.4 mg/L in co-workers with similar air concentrations; he also reports headache and dizziness that clear over the weekend. Two others describe the same weekend-resolving symptoms. No pre-employment cholinesterase or other baseline testing exists, and the plant has never done biological monitoring before.
1. Which urine collection best estimates exposure for these workers, and can o-cresol be used as a strictly quantitative dose metric across the whole 0-95 ppm range? Justify your answer.
Read the worked answer
Collection timing. Urinary o-cresol has an elimination half-life of only a few hours, so the end-of-shift sample (~1.7 g/g creatinine) is the one that reflects that day's absorbed dose; the pre-shift value (~0.35 g/g creatinine) mostly reflects the tail of the previous day's exposure plus dietary/background cresols. The ACGIH BEI for toluene (o-cresol, 0.3 mg/g creatinine, end of shift) is an end-of-shift comparison, so the morning sample cannot be judged against it.
Quantitative use is the weak point. At 95 ppm the workers are at the upper end of the range where toluene clearance becomes capacity-limited; as CYP2E1-mediated metabolism approaches saturation, parent toluene in blood and exhaled air rises disproportionately while the fraction excreted as o-cresol falls. The metabolite therefore under-represents dose at high exposure, i.e., the exposure-response curve for o-cresol flattens exactly where you most need sensitivity.
Practical conclusion: end-of-shift o-cresol is valid for confirming overexposure (1.7 g/g is roughly 5-6x the BEI) and for ranking workers, but should not be converted into a precise ppm estimate. If quantitative internal dose is needed, pair it with exhaled-breath or blood toluene, and always state the sampling time and creatinine correction.
2. Does the obese worker's blood toluene of 1.9 mg/L demonstrate that high adiposity makes him 'more sensitive', or should other explanations be tested first?
Read the worked answer
Adiposity is a plausible contributor but a weak stand-alone explanation, and the exam-relevant reasoning is to test competing explanations before invoking susceptibility.
Arguments for body composition: toluene is lipophilic; a large adipose compartment increases volume of distribution and total body burden, and slow release from fat can prolong blood concentrations and symptoms. A larger person also has a larger absolute uptake at the same ppm.
Competing explanations that must be excluded:
- Sampling time: 2 h post-shift is on the declining phase; small timing differences between workers produce large blood-concentration differences.
- Workload: higher minute ventilation during exertion raises alveolar uptake proportionally, independent of fat.
- Dermal exposure: the worker uses only cotton gloves soaked in cement; skin uptake bypasses first-pass hepatic metabolism and disproportionately raises parent compound in blood.
- Analytical/preanalytical: collection tube, clotting time, and headspace loss.
Judgment: a single blood measurement in one worker cannot attribute the difference to body habitus. The defensible position is that dermal and workload exposures must be documented and controlled first, and that his symptoms-plus-concentration combination warrants removal from exposure pending controls. Note also that a high-Vd worker may show lower peaks but slower clearance, so 'obese = higher peak' is not a reliable rule either way.
3. The plant physician asks whether the urine results 'prove' that the workers were overexposed and what the appropriate next step is. How do you answer?
Read the worked answer
Yes for the group, with caveats for the individual. A group mean end-of-shift o-cresol of 1.7 g/g creatinine is far above the BEI of 0.3 mg/g creatinine and is consistent with the 95 ppm TWA being roughly five times the TLV of 20 ppm (and, importantly, still legal under the OSHA PEL of 200 ppm). Biological monitoring and air monitoring therefore agree, which is the strongest form of evidence.
Caveats:
- A BEI is a guide to control, not a diagnostic threshold; individuals vary several-fold in metabolism and creatinine excretion.
- Creatinine correction is unreliable at extremes of muscle mass, and dilute/concentrated samples distort g/g values.
- The metabolite cannot apportion inhalation versus dermal uptake.
Recommended actions: (1) engineering controls and glove change-out, since dermal uptake is plausible and uncontrolled; (2) repeat end-of-shift air and urine sampling after controls to demonstrate a downward trend; (3) include the symptomatic workers in medical surveillance with attention to CNS effects and, for chronic high exposure, neurobehavioral and hearing endpoints; (4) do not rely on the PEL as evidence of safety.